Indo Tech Transformers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 28, 2025, 10:47 pm

Quick Insight

Indo Tech Transformers Ltd, a key player in the Power Transmission/Equipment sector, currently trades at ₹1,819 with a MarketCap of ₹1,932 Cr. The company's P/E ratio stands at 25.0, reflecting a premium valuation compared to sector averages, while boasting a robust ROE of 25.7% and a stellar ROCE of 37.8%. With a healthy OPM of 15%, Indo Tech Transformers Ltd has maintained a strong financial position with Net Profit at ₹64 Cr and Reserves of ₹270 Cr. The company's low Borrowings of ₹8 Cr and comfortable ICR of 17.77x indicate a sound capital structure. However, the high P/BV ratio of 4.82x may suggest an overvaluation compared to industry peers.

One of Indo Tech Transformers Ltd's key strengths lies in its impressive profitability metrics, reflected in the strong ROE and ROCE figures. Additionally, the company's significant promoter holding of 75.00% underscores their confidence in the business. However, risks include the relatively low FII and DII holdings, which could impact liquidity and investor confidence. Looking ahead, increasing FII and DII participation could potentially enhance market sentiment and drive up the share price, while any deterioration in the company's CCC of 135 days could signal operational inefficiencies and pose a threat to its financial health.

In conclusion, while Indo Tech Transformers Ltd exhibits robust financial performance and stability, investors should closely monitor key metrics such as liquidity, operational efficiency, and market valuation to make informed investment decisions in this sector.

Competitors of Indo Tech Transformers Ltd

All Competitor Stocks of Indo Tech Transformers Ltd

Quarterly Result

Last Updated: August 20, 2025, 9:10 am

Below is a detailed analysis of the quarterly data for Indo Tech Transformers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 164.00 Cr.. The value appears to be declining and may need further review. It has decreased from 206.00 Cr. (Mar 2025) to 164.00 Cr., marking a decrease of 42.00 Cr..
• For Expenses, as of Jun 2025, the value is 140.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 185.00 Cr. (Mar 2025) to 140.00 Cr., marking a decrease of 45.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 3.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Mar 2025) to 15.00%, marking an increase of 5.00%.
• For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 1.00 Cr..
• For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be increasing, which may not be favorable. It has increased from 14.00% (Mar 2025) to 23.00%, marking an increase of 9.00%.
• For Net Profit, as of Jun 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21.00 Cr. (Mar 2025) to 19.00 Cr., marking a decrease of 2.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 18.05. The value appears to be declining and may need further review. It has decreased from 19.76 (Mar 2025) to 18.05, marking a decrease of 1.71.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:38 pm

Growth

Last Updated: September 5, 2025, 7:25 am

Balance Sheet

Last Updated: July 25, 2025, 3:01 pm

Below is a detailed analysis of the balance sheet data for Indo Tech Transformers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 270.00 Cr.. The value appears strong and on an upward trend. It has increased from 207.00 Cr. (Mar 2024) to 270.00 Cr., marking an increase of 63.00 Cr..
• For Borrowings, as of Mar 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 5.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 3.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 150.00 Cr.. The value appears to be improving (decreasing). It has decreased from 164.00 Cr. (Mar 2024) to 150.00 Cr., marking a decrease of 14.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 438.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 386.00 Cr. (Mar 2024) to 438.00 Cr., marking an increase of 52.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 50.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Mar 2024) to 50.00 Cr., marking an increase of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 6.00 Cr., marking an increase of 6.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 383.00 Cr.. The value appears strong and on an upward trend. It has increased from 337.00 Cr. (Mar 2024) to 383.00 Cr., marking an increase of 46.00 Cr..
• For Total Assets, as of Mar 2025, the value is 438.00 Cr.. The value appears strong and on an upward trend. It has increased from 386.00 Cr. (Mar 2024) to 438.00 Cr., marking an increase of 52.00 Cr..

Notably, the Reserves (270.00 Cr.) exceed the Borrowings (8.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Indo Tech Transformers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 44.12. This value is within the healthy range. It has increased from 24.20 (Mar 23) to 44.12, marking an increase of 19.92.
• For Diluted EPS (Rs.), as of Mar 24, the value is 44.12. This value is within the healthy range. It has increased from 24.20 (Mar 23) to 44.12, marking an increase of 19.92.
• For Cash EPS (Rs.), as of Mar 24, the value is 48.75. This value is within the healthy range. It has increased from 28.74 (Mar 23) to 48.75, marking an increase of 20.01.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 204.48. It has increased from 160.93 (Mar 23) to 204.48, marking an increase of 43.55.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 204.48. It has increased from 160.93 (Mar 23) to 204.48, marking an increase of 43.55.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 474.21. It has increased from 349.25 (Mar 23) to 474.21, marking an increase of 124.96.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 62.05. This value is within the healthy range. It has increased from 31.30 (Mar 23) to 62.05, marking an increase of 30.75.
• For PBIT / Share (Rs.), as of Mar 24, the value is 57.43. This value is within the healthy range. It has increased from 26.76 (Mar 23) to 57.43, marking an increase of 30.67.
• For PBT / Share (Rs.), as of Mar 24, the value is 53.94. This value is within the healthy range. It has increased from 24.20 (Mar 23) to 53.94, marking an increase of 29.74.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 44.12. This value is within the healthy range. It has increased from 24.20 (Mar 23) to 44.12, marking an increase of 19.92.
• For PBDIT Margin (%), as of Mar 24, the value is 13.08. This value is within the healthy range. It has increased from 8.96 (Mar 23) to 13.08, marking an increase of 4.12.
• For PBIT Margin (%), as of Mar 24, the value is 12.11. This value is within the healthy range. It has increased from 7.66 (Mar 23) to 12.11, marking an increase of 4.45.
• For PBT Margin (%), as of Mar 24, the value is 11.37. This value is within the healthy range. It has increased from 6.92 (Mar 23) to 11.37, marking an increase of 4.45.
• For Net Profit Margin (%), as of Mar 24, the value is 9.30. This value is within the healthy range. It has increased from 6.92 (Mar 23) to 9.30, marking an increase of 2.38.
• For Return on Networth / Equity (%), as of Mar 24, the value is 21.57. This value is within the healthy range. It has increased from 15.03 (Mar 23) to 21.57, marking an increase of 6.54.
• For Return on Capital Employeed (%), as of Mar 24, the value is 27.30. This value is within the healthy range. It has increased from 16.38 (Mar 23) to 27.30, marking an increase of 10.92.
• For Return On Assets (%), as of Mar 24, the value is 12.26. This value is within the healthy range. It has increased from 8.54 (Mar 23) to 12.26, marking an increase of 3.72.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.02. This value is within the healthy range. It has decreased from 0.06 (Mar 23) to 0.02, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.48. It has increased from 1.38 (Mar 23) to 1.48, marking an increase of 0.10.
• For Current Ratio (X), as of Mar 24, the value is 2.03. This value is within the healthy range. It has increased from 1.97 (Mar 23) to 2.03, marking an increase of 0.06.
• For Quick Ratio (X), as of Mar 24, the value is 1.28. This value is within the healthy range. It has decreased from 1.41 (Mar 23) to 1.28, marking a decrease of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.14. This value is within the healthy range. It has decreased from 4.50 (Mar 23) to 4.14, marking a decrease of 0.36.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 17.77. This value is within the healthy range. It has increased from 12.23 (Mar 23) to 17.77, marking an increase of 5.54.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 13.63. This value is within the healthy range. It has increased from 10.46 (Mar 23) to 13.63, marking an increase of 3.17.
• For Enterprise Value (Cr.), as of Mar 24, the value is 993.68. It has increased from 152.65 (Mar 23) to 993.68, marking an increase of 841.03.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.97. This value is within the healthy range. It has increased from 0.41 (Mar 23) to 1.97, marking an increase of 1.56.
• For EV / EBITDA (X), as of Mar 24, the value is 15.08. This value exceeds the healthy maximum of 15. It has increased from 4.59 (Mar 23) to 15.08, marking an increase of 10.49.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.08. This value is within the healthy range. It has increased from 0.49 (Mar 23) to 2.08, marking an increase of 1.59.
• For Price / BV (X), as of Mar 24, the value is 4.82. This value exceeds the healthy maximum of 3. It has increased from 1.07 (Mar 23) to 4.82, marking an increase of 3.75.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.08. This value is within the healthy range. It has increased from 0.49 (Mar 23) to 2.08, marking an increase of 1.59.
• For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 23) to 0.04, marking a decrease of 0.09.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness